Molecular Testing and Clinical Diagnosis - PowerPoint PPT Presentation

About This Presentation
Title:

Molecular Testing and Clinical Diagnosis

Description:

Since each of the DNA templates can make 100 to 1000 copies of RNA amplicon, this expansion can result in the production of 10 billion amplicon in 15 to 30 minutes. – PowerPoint PPT presentation

Number of Views:113
Avg rating:3.0/5.0
Slides: 28
Provided by: khon5
Category:

less

Transcript and Presenter's Notes

Title: Molecular Testing and Clinical Diagnosis


1
Molecular Testing and Clinical Diagnosis
  • Amplified nucleic acid testing
  • Part III

2
Objectives At the end of this lesson the
student will
  • Describe and evaluate types of target sequences
    (DNA, mRNA, tRNA, rRNA) (C3)
  • Describe and compare amplification processes
    including (C3)
  • Basic steps of an amplification process
  • Principles of methods available
  • PCR, LCR, SDA, NASBA, TMA
  • List and describe the function PCR components in
    the reaction mix (C2)
  • Describe the variations of PCR process (C2)
  • LCR
  • Reverse Transcription-PCR
  • Real time PCR

3
Objectives At the end of this lesson the
student will
  • Explain the application of PCR to STR testing
    (C2)
  • Paternity testing
  • Forensic testing
  • RFLP mapping
  • Describe the significance of the following PCR
    considerations (C2, A2)
  • Contamination
  • Quality control
  • Lab space allocation

4
Strand Displacement Amplification- BDPobeTec ET
system
  • One hour assay
  • fluorescence detection
  • automated and semi-automated systems
  • pre-dispensed reagent devices

5
Strand Displacement Process
  • step 1 primer hybridization
  • step 2 primer extensions by DNA polymerase
    leads to strand displacement
  • step 3 extended probe binds complimentary strand
  • step 4 probe is extended creating BsoBI site
  • step 5 BsoBI cleaves dsDNA

6
(No Transcript)
7
Detection linked with amplification.
Target must be amplified and double stranded to
enable the restriction enzyme to function.
Fluorescence only occurs when there is cleavage.
8
SDA lends itself to automation since it is
isothermal.
9
Transcription-Mediated Amplification
  • RNA transcription amplification system using two
    enzymes RNA polymerase and reverse transcriptase
  • Isothermal amplification of nucleic acid target
    producing RNA product amplification
  • Rapid kinetics results in excess of ten
    billion-fold amplification within 15-30 minutes
  • Combined with Hybridization Protection Assay
    detection in a single tube format

10
Transcription-Mediated Amplification Components
  • Primers Oligonucleotides that hybridize to
    target and initiate the reaction
  • Nucleotides
  • Enzymes drive the reaction
  • T7 RNA polymerase
  • transcribes RNA from DNA
  • Reverse transcriptase (MLV)
  • synthesizes DNA from RNA or DNA
  • RNAse H activity degrades RNA after it has been
    copied into DNA

11
Transcription-Mediated Amplification
12
TMA Gen-Probe Second GenerationAPTIMATM Assays
  • Target Capture sample processing partially
    purifies target nucleic acid
  • Transcription-Mediated Amplification-- amplified
    target
  • Dual Kinetic Assay (DKA) technology
    simultaneously detects two organisms

13
Gen-Probe Proprietary Target Capture Technology
N
Bead
TTTTTTTTTTTTTT
Oligo
TTTTTTTTTTTTTT
Capture
Oligo "Tail"
one
micron
Magnet
AAAAAAAAAAAAAAAAAA
magnetic

TTTTTTTTTTTTTT
particle
TTTTTTTTTTTTTT
.....GAUCGAUCCCCCCUAGCGGUGCAUCUAGCAUCUA....
TTTTTTTTTTTTTT
GGATCGCCACGTAGATCGGCCTC
TTTTTTTTTTTTTT

TTTTTTTTTTTTTT
S
Capture
Sequence
These are washed away
Cell debris
Protein
Target
Sequence
non-specific
Plasma
DNA/RNA
14
Detection by Dual Kinetic Assay (DKA) Technology
  • Hybridization Protection Assay (HPA) Technology
  • Two modified acridinium
  • ester labels with different
  • light-off kinetics on
  • different DNA probes
  • Flasher fast
  • Glower slow
  • Simultaneous detection of different organisms

15
Dual Kinetic Assay (DKA)
120,000
CT GC
CT
100,000
GC
80,000
RLU
60,000
40,000
20,000
0
.52
.68
.84
1.00
1.16
1.32
1.48
1.64
1.80
1.96
.04
.20
.36
Time in Seconds
16
TMA Amplicon Production
TMA Amplicon Production
Starting with 1000 copies of Target
1E14
1E12
1E10
1E8
Amplicon copies
1E6
1E4
1E2
1E0
0
5
10
15
20
25
30
35
40
45
50
55
60
Time (min.)
17
Gen-Probe Instrumentation Systems
  • Fully automated, APTIMATM amplification assays
    for TIGRISTM
  • Target Capture system
  • VIDAS dual platform Amplified assays and
    immunoassays

from bioMérieux
18
Challenges with Current Nucleic Acid
Amplification Tests
  • Carry-over contamination can cause false
    positives
  • Verification of positive results is difficult
  • Inhibition can cause false negatives
  • Compared with current microbiology tests
  • Increased labor
  • Higher cost
  • Low throughput

19
Methods for Control of Carryover Contamination in
automated TMA Assays
  • Unidirectional workflow
  • Single-tube format
  • Oil as a barrier to the environment
  • HPA format eliminates wash steps and potential
    aerosols
  • Treatment of RNA amplicon with detection reagents
  • Bleach destroys nucleic acids

20
Comparison of TMA with PCR and LCR Amplification
Methods
TMA (
Gen-Probe )
PCR (
Roche )
LCR ( Abbott )
Ligase DNA polymerase
RNA polymerase Reverse transcription
Enzymes
DNA polymerase
Thermal
Isothermal reaction
Thermal cycling
Thermal cycling
Conditions
Amplified
RNA
DNA
DNA
Product
Homogeneous
Wash step
assay no wash
Wash step
required
Wash step required
steps
Detection System
Chemiluminescence
Absorbance
Fluorescence
Special
Thermal cycler,
equipment
microtiter plate
Thermal cycler,
Luminometer
needed
reader/washer
LCx instrument
21
(No Transcript)
22
Gen-Probe HIV-1/HCV dual-assay protocol for blood
supply



Step One SampleProcessing Extract RNA 90
minutes (Hybridized target captured on to
microparticles)
Step Two TMA Add Amplification Reagent, Oil
Reagent 10 minutes 41.5C Add Reverse
Transcriptase, RNA Polymerase 60 minutes 41.5C
Step Three HPA Add Probe Reagent(Hybridizes to
amplicon) 15 minutes 60C Add Selection
Reagent 10 minutes 60C Read in Luminometer

23
Pooling Scheme
16
16
16
16
128 Pool
16
16
128 Donations
16
16
24
Resolution Testing
16
16
16
16
128
16
16
1
1
Reactive Pool
Identification of Single Donation
Test Primary Pools
16
16
25
HCV Panel 6211 Virologic/Serologic Profile
46 Days
S/CO
HCV PCR Quantitation
Days
? PCR
E991685 7-14-99 25
26
Summary Amplification Methods
  • Much like a culture technique, they increase
    likelihood of detection and identification
  • Enzymes are used to increase target sequence for
    detection
  • May be automated or semi-automated more easily if
    isothermal

27
Summary Amplification Methods
  • Increased sensitivity
  • amplification
  • detection systems
  • Specificity
  • primers
  • probe/detection systems
Write a Comment
User Comments (0)
About PowerShow.com